Regenx Tech Corp (RGXTF): Preliminary commercial production has co...

Preliminary commercial production has commenced at the EnviroCircuit

TPX · 2019-12-31T15:54:30.4670000Z

Preliminary commercial production has commenced at the EnviroCircuit E-Waste processing facility located in Surrey, BC, Canada. Starting with a single shift per day, the Company will incrementally increase process throughput to 5 tonnes per day of printed circuit boards by January 1, 2020. Additional shifts will be added to achieve the targeted plant capacity of 20 tonnes per day (6,000 tonnes per year) by end of June 2020. ... Duane Nelson, President and CEO comments: “We are excited to enter the revenue stage of our operations and the positive response from global electronics manufacturers, OEM’s and recyclers is very encouraging. We are in a unique situation within a rapidly expanding and under-developed sector. The results of our extensive commercial market analysis demonstrate a vast emerging global market now estimated to exceed 110 million tonnes annually by 2026. OEM’s and E-waste recyclers worldwide are increasingly seeking economic and sustainable E-waste processing solutions. EnviroLeach’s proprietary, patent pending technology suite offers the only true cost-effective, environmentally friendly and sustainable solution. Our team’s priorities are to secure immediate full capacity feedstock contracts for our initial plant and determine the location and capacity of our next facility.” https://mineworx.net/wp-content/uploads/2019/11/EnviroCircuit-E-Waste-Facility-Commences-Production-.pdf

Play Episode

5min

Proactive - Interviews for investors

Bitwise’s Bradley Duke on the BTCG ETP: gold & Bitcoin combined

Bitwise Asset Management European head Bradley Duke talked with Proactive about Bitcoin’s recent price movements and the company’s latest product launch. Duke discussed the volatility of Bitcoin, noting both its tailwinds—such as increased demand from corporate investors and national reserves—and the headwinds, including geopolitical uncertainties. He pointed out that institutional investors are turning instead to alternative safe-haven assets like gold. The conversation then shifted to Bitwise’s latest product, Bitwise Diaman Bitcoin & Gold ETP (BTCG), which launched today on Euronext in Paris and Amsterdam. Duke explained that the product is a collaboration with Diaman Partners, part of asset manager Azimut. The ETP dynamically allocates between Bitcoin and gold based on an index that considers drawdowns and recovery rates. "We’ve looked at the performance of this index versus the S&P 500, Nasdaq 100, and gold alone, and it has outperformed considerably," said Duke. He emphasised that while past performance is no guarantee of future results, the product arrives at a time when institutions are actively seeking alternative safe-haven assets. For more insights and interviews, visit Proactive’s YouTube channel. Don’t forget to like, subscribe, and enable notifications for updates. #Bitcoin #Gold #BTCG #Bitwise #CryptoInvesting #DigitalAssets #SafeHaven #ETP #Investment #Markets

Proactive - Interviews for investors

BioHarvest Sciences achieves breakthrough in Liver health with Olive Cell compound

BioHarvest Sciences has announced a significant advancement in liver health research, with new in vitro test results demonstrating the efficacy of its proprietary Olive Cell compound in reducing fat accumulation in human liver cells. CEO Ilan Sobel shared the news with Steve Darling from Proactive, highlighting the compound’s potential in addressing non-alcoholic fatty liver disease (NAFLD)—a condition that affects 30–40% of U.S. adults and currently has limited FDA-approved treatment options. The latest studies revealed that the Olive Cell compound mitigated fat accumulation in both a liver steatosis model and experimental models of liver fibrosis. Additionally, it reduced collagen type 1 levels in XL-2 cells, a key marker of fibrosis progression, further reinforcing its therapeutic potential. BioHarvest attributes these promising results to the compound’s high levels of Verbascoside, a bioactive polyphenol with anti-inflammatory and antioxidant properties. Looking ahead, the company plans to conduct further studies in 2025, with the goal of launching Olive Cell as a nutraceutical product in 2026. Meanwhile, BioHarvest is also exploring pharmaceutical partnerships to bring the compound to market through a CDMO (Contract Development and Manufacturing Organization) model. With these groundbreaking findings, BioHarvest Sciences is positioning itself at the forefront of liver health innovation, offering a potential new solution for millions affected by NAFLD and liver fibrosis. #proactivinvestors #nasdaq #bhst #pharma #biotech #hearthealth #fattyliverdisease #BioHarvestSciences, #IlanSobel, #RevenueGrowth, #NasdaqListing, #IlanSobel #VINIA #HealthTech #Biotech LiverHealth #OliveCell #Verbascoside #NonAlcoholicFattyLiver #SupplementScience #HealthInnovation

Proactive - Interviews for investors

Lisata Therapeutics expands drug discovery with GATC AI collaboration

Lisata Therapeutics Inc (NASDAQ:LSTA) CEO David Mazzo talked with Proactive about the company’s strategic collaboration with GATC Health, a leader in artificial intelligence-driven drug discovery. Mazzo explained that GATC’s technology, which is recognized by Lloyd’s of London for clinical trial risk assessment, will be used to analyze Lisata’s lead candidate, certepetide, and identify potential new drug combinations. Mazzo highlighted that this collaboration will optimize Lisata’s ongoing cancer research, including trials in pancreatic ductal adenocarcinoma, cholangiocarcinoma, and other cancers. He noted that GATC’s AI technology can perform billions of simulations rapidly, potentially reducing the cost and risk of drug development. Discussing Lisata’s 2025 outlook, Mazzo described it as a "data-rich year," with upcoming results from the ASCEND trial and other studies. He emphasized the potential for certepetide in combination with immunotherapy and the company’s ongoing discussions with regulatory agencies and potential partners. To watch more interviews like this, visit Proactive’s YouTube channel. Don't forget to like this video, subscribe, and enable notifications for future updates. #LisataTherapeutics #Biotech #CancerResearch #AIinHealthcare #DrugDevelopment #ClinicalTrials #GATCHealth #Pharma #Oncology #Investing

Proactive - Interviews for investors

Major investment: AuKing’s $5M earn-in deal

AuKing Mining Ltd managing director Paul Williams joins Proactive’s Jonathan Jackson to discuss the company’s right to earn up to a 50% stake in Orion Resources Pty Ltd, which is acquiring the Cloncurry Gold Project in northwest Queensland. The agreement extends a prior deal allowing AuKing to earn a 15% stake through $1.5 million in project-related expenditure. Under the new terms, AuKing must invest $5 million in project development by June 30, 2027. Orion is finalising the acquisition of the Cloncurry Gold Project, the Lorena processing plant, and the Mt Freda/Golden Mile deposits. The company is also considering processing material from the Tick Hill mine and tailings. AuKing’s investment will support exploration, drilling, and resource estimation work, particularly at Mt Freda/Golden Mile, as well as refurbishment of the Lorena plant. Upon completing the $5 million earn-in, AuKing and Orion will form an incorporated joint venture, with AuKing holding a 50% share. If AuKing does not meet the expenditure requirement, its interest will lapse. Orion will fund the purchase of the Cloncurry Gold Project independently, and AuKing has no further automatic acquisition rights beyond the 50% stake. ➡️ Watch the full interview for more insights! 🔔 Don’t forget to like, subscribe, and turn on notifications for more updates from Proactive. #AuKingMining #GoldMining #MiningStocks #CloncurryGold #OrionResources #Investing #ASX #GoldExploration #MiningUpdates #GoldProduction

Followers	0
Posts	40567
Boards Moderated	4
Alias Born	10/24/2013

Volume:	23,300
Day Range:	0.0117 - 0.0135
Bid:	0.0099
Ask:	0.0135
Last Trade Time:	1:01:04 PM EDT
Total Trades:	4

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

RGXTF Detailed Quote

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Go Ad-Free